T0	Participants 92 146	transurethral resection of superficial bladder cancer]
T1	Participants 222 351	prophylactic intravesical instillation of pirarubicin (THP) prior to transurethral resection (TUR) of superficial bladder cancer.
T2	Participants 363 374	63 patients
T3	Participants 1301 1328	superficial bladder cancer.